Dr Pierre Emile Etienne, MD | |
3497 Reservoir Rd, Enosburg Falls, VT 05450-5966 | |
(860) 333-3252 | |
Not Available |
Full Name | Dr Pierre Emile Etienne |
---|---|
Gender | Male |
Speciality | Psychiatry & Neurology - Geriatric Psychiatry |
Location | 3497 Reservoir Rd, Enosburg Falls, Vermont |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1831849090 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084P0805X | Psychiatry & Neurology - Geriatric Psychiatry | 1.031592 (Connecticut) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Pierre Emile Etienne, MD 3497 Reservoir Rd, Enosburg Falls, VT 05450-5966 Ph: (860) 333-3252 | Dr Pierre Emile Etienne, MD 3497 Reservoir Rd, Enosburg Falls, VT 05450-5966 Ph: (860) 333-3252 |
News Archive
The virus that is causing alarm among global public health authorities after it killed a man in Jeddah, Saudi Arabia earlier this year and is now linked to two other cases of disease is a novel type of coronavirus most closely related to viruses found in bats, according to a genetic analysis to be published in mBio-, the online open-access journal of the American Society for Microbiology, on November 20.
Springer is launching a new quarterly journal Translational Stroke Research, which aims to help translate scientific discoveries from basic stroke research into the development of new strategies for prevention, assessment, treatment and repair after stroke and other forms of neurotrauma. The first issue will appear in March 2010.
Wake up, America, and lose some weight - it's keeping you tired and prone to accidents. Three studies being presented today at sleep 2012 conclude that obesity and depression are the two main culprits making us excessively sleepy while awake.
Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced the U.S. Food and Drug Administration (FDA) has granted marketing approval for METOZOLV™ ODT (metoclopramide HCl) 5mg and 10mg orally disintegrating tablets. METOZOLV ODT is indicated for the relief of symptoms in adults associated with acute and recurrent diabetic gastroparesis and for the treatment of short-term therapy (4-12 weeks) for adults with symptomatic documented gastroesophageal reflux disease (GERD) who fail to respond to conventional therapy1.
› Verified 6 days ago